InvestorsHub Logo
Followers 28
Posts 4351
Boards Moderated 1
Alias Born 09/22/2006

Re: maumar post# 7307

Tuesday, 12/13/2022 6:24:42 PM

Tuesday, December 13, 2022 6:24:42 PM

Post# of 8590
The Tepezza deal with Horizon goes back two years ago to December 2020 and according to Halozyme's web site it has not gotten past phase 1.
What is not clear to me is how Amgen's acquisition will change the dynamic. Unless I'm mistaken, Amgen has not entered into any deal with Halozyme, so I wonder what their commitment is to Enhanze subcu formulation. Horizon has not been in a particular hurry and Amgen has shown no interest, so I'm skeptical that Amgen/Horizon is a meaningful transaction for Halozyme.

https://www.fiercepharma.com/drug-delivery/horizon-pays-halozyme-190m-to-develop-subq-thyroid-eye-disease-med

https://halozyme.com/enhanze/#pipeline_group_1

The more you know, the less you don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News